Skip to content

In the BioHarmony Drug Report Database

Perindopril arginine

Prestalia (perindopril arginine) is a small molecule pharmaceutical. Perindopril arginine was first approved as Prestalia on 2015-01-21. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. Prestalia's patent is valid until 2029-10-05 (FDA).
Trade Name Prestalia
Common Name Perindopril arginine
Indication diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction
Drug Class Antihypertensives (ACE inhibitors)
Perindopril arginine
Get full access now